Clinico-molecular characteristics of Chinese primary non-small cell lung cancer patients with compound EGFR mutations

被引：0
|
作者：
Duan, J. [1 ]
Bai, H. [1 ]
Wang, X. [1 ]
Wan, R. [1 ]
Cheng, H. [2 ]
Wang, H. [2 ]
Lou, F. [2 ]
Cao, S. [2 ]
Wang, J. [1 ]
机构：
[1] Chinese Acad Med Sci & Peking Union Med Coll, Mol Oncol, Dept Med Oncol, Natl Canc Ctr,Canc Hosp, Beijing, Peoples R China
[2] Beijing Acornmed Biotechnol Co Ltd, Dept Med, Beijing, Peoples R China
来源：
ANNALS OF ONCOLOGY | 2019年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
500P
引用
收藏
页数：1
相关论文
共 50 条
  • [41] CLINICAL CHARACTERISTICS OF NON-SMALL CELL LUNG CANCER WITH EGFR GENE MUTATIONS IN EXON 20
    Miyanaga, A.
    Akagi, K.
    Takeuchi, S.
    Kurimoto, F.
    Iijima, Y.
    Yoshino, N.
    Mikami, I.
    Akiyama, H.
    Sakai, H.
    LUNG CANCER, 2009, 64 : S54 - S54
  • [42] Evaluation of molecular methods for plasma detection of EGFR mutations in non-small cell lung cancer
    Lee, Kyunghoon
    Lim, Sangeun
    Lee, Yun-Gyoo
    Kim, Haejeung
    Lee, Seungjun
    Yu, Hui-Jin
    Park, Hyosoon
    Kwon, Min-Jung
    Woo, Hee-Yeon
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2022, 18 (06) : 595 - 604
  • [43] Clinical and molecular characteristics of Chinese non-small cell lung cancer patients with ERBB2 transmembrane domain mutations
    Fan, Yun
    Qiu, Jinrong
    Yu, Ruoying
    Cao, Ran
    Chen, Xiaoxi
    Ou, Qiuxiang
    Wu, Xue
    Shao, Yang W.
    Nagasaka, Misako
    Zhang, Jiexia
    Ou, Sai-Hong Ignatius
    MOLECULAR ONCOLOGY, 2020, 14 (08) : 1731 - 1739
  • [44] The Prevalence and Genotype Distribution of Dual in Cis EGFR Mutations in Chinese Advanced Non-Small Cell Lung Cancer Patients
    Li, M.
    Zhou, C.
    Yang, J.
    Lu, S.
    Zheng, D.
    Hu, J.
    Zeng, H.
    Lu, Y.
    Lu, K.
    Mao, X.
    Zhang, H.
    Zhang, N.
    Hu, C.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2221 - S2222
  • [45] Molecular characteristics of non-small cell lung cancer
    Nacht, M
    Dracheva, T
    Gao, YH
    Fujii, T
    Chen, YD
    Player, A
    Akmaev, V
    Cook, B
    Dufault, M
    Zhang, M
    Zhang, W
    Guo, MZ
    Curran, J
    Han, S
    Sidransky, D
    Buetow, K
    Madden, SL
    Jen, J
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (26) : 15203 - 15208
  • [46] Molecular Characteristics of HER2 Mutations in Non-Small Cell Lung Cancer
    Wei, X.
    Gao, X.
    Zhang, X.
    Chen, Z.
    Wu, Y.
    Zhou, Q.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S848 - S849
  • [47] Disparities of EGFR Mutations Between Biopsy and Rebiopsy in Non-Small Cell Lung Cancer Patients
    Yan, S.
    Li, H.
    Liu, X.
    Liu, Y.
    Ma, L.
    Liu, Y.
    Cheng, Y.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (12) : S1088 - S1088
  • [48] EGFR and KRAS mutations in Turkish non-small cell lung cancer patients: a pilot study
    Bircan, Sema
    Baloglu, Huseyin
    Kucukodaci, Zafer
    Bircan, Ahmet
    MEDICAL ONCOLOGY, 2014, 31 (08)
  • [49] EGFR and KRAS mutations in Turkish non-small cell lung cancer patients: a pilot study
    Sema Bircan
    Huseyin Baloglu
    Zafer Kucukodaci
    Ahmet Bircan
    Medical Oncology, 2014, 31
  • [50] Assessment of EGFR mutations in patients diagnosed of squamous non-small cell lung cancer (NSCLC).
    Lobo, Francisco
    Domine, Manuel
    Rojo, Federico
    Izarzugaza, Yann
    Leon, Ana
    Casado, Victoria
    Jesus Fernandez-Acenero, Maria
    Rubio, Gustavo
    Ignacio Martin-Valades, Jose
    Luis Arranz, Juan
    Serrano, Gloria
    Carames, Cristina
    Cordova, Sharon
    Madoz, Juan
    Zazo, Sandra
    Rincon, Raul
    Canadas, Carmen
    Perez-Gonzalez, Nuria
    Campos, Angel
    Garcia-Foncillas, Jesus
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
12345